UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.07B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Costco
COST
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Advanced Micro Devices
AMD
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$274M |
| 2 |
UnitedHealth
UNH
|
+$207M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$204M |
| 4 |
Home Depot
HD
|
+$203M |
| 5 |
Qualcomm
QCOM
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.71% |
| 2 | Healthcare | 12.08% |
| 3 | Financials | 11.18% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
TFI International
TFII
$11.5B
| $429K | ﹤0.01% |
+2,692
| New | +$385K |
|
|
MLNK
2277
DELISTED
MeridianLink
MLNK
| $429K | ﹤0.01% |
22,948
| – | – |
|
2278
E.W. Scripps
SSP
$304M
| $429K | ﹤0.01% |
109,117
+6,456
| +6% | +$38.6K |
|
2279
NextDecade
NEXT
$1.78B
| $419K | ﹤0.01% |
73,814
| – | – |
|
2280
Stem
STEM
$52.7M
| $417K | ﹤0.01% |
9,529
+121
| +1% | +$6.73K |
|
2281
Aehr Test Systems
AEHR
$3.36B
| $416K | ﹤0.01% |
33,566
| – | – |
|
2282
Novavax
NVAX
$1.31B
| $411K | ﹤0.01% |
86,065
+15,272
| +22% | +$70.8K |
|
2283
Thryv Holdings
THRY
$108M
| $410K | ﹤0.01% |
18,447
| – | – |
|
2284
DocGo
DCGO
$62.6M
| $405K | ﹤0.01% |
100,341
| – | – |
|
|
CDMO
2285
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $404K | ﹤0.01% |
60,331
| – | – |
|
2286
Cellebrite
CLBT
$3.99B
| $403K | ﹤0.01% |
36,400
| – | – |
|
2287
Mitek Systems
MITK
$834M
| $400K | ﹤0.01% |
28,399
| – | – |
|
2288
FuboTV Inc
FUBO
$273M
| $399K | ﹤0.01% |
21,050
+238
| +1% | +$6.21K |
|
2289
Ubiquiti
UI
$34.3B
| $399K | ﹤0.01% |
3,443
| – | – |
|
2290
Microvision
MVIS
$79M
| $399K | ﹤0.01% |
14,449
| – | – |
|
2291
MacroGenics
MGNX
$257M
| $396K | ﹤0.01% |
+26,900
| New | +$407K |
|
2292
Farmers National Banc Corp
FMNB
$930M
| $393K | ﹤0.01% |
29,453
| – | – |
|
2293
Frontier Group Holdings
ULCC
$1.7B
| $392K | ﹤0.01% |
48,341
| – | – |
|
|
DHIL
2294
DELISTED
Diamond Hill
DHIL
| $385K | ﹤0.01% |
2,498
-1,292
| -34% | -$201K |
|
2295
AnaptysBio
ANAB
$1.68B
| $381K | ﹤0.01% |
16,921
| – | – |
|
2296
Mission Produce
AVO
$1.17B
| $379K | ﹤0.01% |
31,963
| – | – |
|
|
SLNO
2297
DELISTED
Soleno Therapeutics
SLNO
| $378K | ﹤0.01% |
+8,824
| New | +$399K |
|
2298
Titan Machinery
TITN
$445M
| $376K | ﹤0.01% |
15,160
| – | – |
|
|
ONC
2299
BeOne Medicines Ltd
ONC
$39.4B
| $374K | ﹤0.01% |
2,389
-1,597
| -40% | -$257K |
|
2300
AerSale
ASLE
$279M
| $373K | ﹤0.01% |
51,977
| – | – |
|
Similar funds
UBS AM's Q1 2024 Portfolio in Review
As of Q1 2024, UBS AM held 2,593 positions worth $281B, up 11% from $254B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.9%. UBS AM opened 53 new positions and exited 73, leaving the 2,593-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2024 buy was iShares Core MSCI EAFE ETF: 57,224,039 shares worth $4.25B.
- UBS AM added most to Costco in Q1 2024, an estimated $252M increase.
- UBS AM's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $274M.
- UBS AM fully exited Splunk Inc in Q1 2024, selling an estimated $204M.
- UBS AM's ten largest holdings make up 27% of its $281B portfolio in Q1 2024.
- UBS AM opened 53 new positions and closed 73 in Q1 2024.
- UBS AM's portfolio value rose 11% quarter-over-quarter to $281B.
Based on UBS AM's 13F filing for Q1 2024, filed 15 May 2024.